Advertisement

Topics

Merck Merck Company Profile

15:07 EDT 20th June 2019 | BioPortfolio

For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.


News Articles [1738 Associated News Articles listed on BioPortfolio]

Merck Ventures: Success in funding early innovation

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core busi...

FDA Gives Merck Thumbs-Up for Two New Indications

Merck & Co. found itself with two new approvals this week. The FDA approved Lynparza (codeveloped by AstraZeneca and Merck) and also approved Merck's Keytruda. Both of these drugs were approved for ne...

Merck shakes up C-suite as Schechter departs

Adam Schechter, who has led Merck's human health unit since 2010, will step down by year's end. In his place, Merck will promote two execs from within.

Merck To Buy Antelliq For EUR 2.1 Bln Plus Debt Of EUR 1.15 Bln

KENILWORTH (NJ) (dpa-AFX) - Merck & Co. Inc. (MRK) said that it agreed to acquire privately held Antelliq Group from funds advised by BC Partners.Merck said it will make a cash payment of approxim...

Merck: Chance von 99 Prozent

Die im DAX notierte Merck und der chinesische Internet-Gigant Tencent kooperieren. Konkret: Die Zusammenarbeit mit Tencent wird sich nach Auskunft von Merck in erster Linie darauf konzentrieren, da...

Merck Serono: Launching a New Corporate Venture Fund

In this episode of PharmaTelevision News Review, Paul Larsmon talks with Roel Bulthuis, Head at Merck Serono Ventures. Filmed at BIO-Europe 2009, they discuss: • Merck Serono's new corporate venture...

Merck's Full Court Press On Oncology

Earlier this week, Merck entered into an agreement to acquire Tilos Therapeutics for up to $773 million. Such acquisitions demonstrate how heavily invested Merck is in immuno-oncology, an area in whic...

Roche signs companion Dx development deal with Merck

Roche Holding and Merck have agreed to partner on a companion diagnostic test to identify patients eligible to receive Merck' -More- 

Drugs and Medications [140 Associated Drugs and Medications listed on BioPortfolio]

Guanidine hydrochloride [merck sharp & dohme corp.]

GUANIDINEHYDROCHLORIDETablets

Sylatron [merck sharp & dohme corp.]

These highlights do not include all the information needed to use SYLATRON safely and effectively. See full prescribing information for SYLATRON. SYLATRON™ (peginterferon alfa-2b) for injection, for...

Pregnyl [organon usa inc.]

Pregnyl (chorionic gonadotropin for injection USP)

Daptomycin [xellia pharmaceuticals usa llc]

These highlights do not include all the information needed to use DAPTOMYCIN FOR INJECTION safely and effectively. See full prescribing information for DAPTOMYCIN FOR INJECTION. DAPTOMYCIN for injecti...

Daptomycin [hospira, inc.]

These highlights do not include all the information needed to use DAPTOMYCIN FOR INJECTION safely and effectively. See full prescribing information for DAPTOMYCIN FOR INJECTION. DAPTOMYCIN for injecti...

PubMed Articles [21 Associated PubMed Articles listed on BioPortfolio]

Budget Impact Analysis of Rotavirus Vaccine Adoption in the Childhood Immunization Schedule of Iran.

To examine the budget impact of introducing the RotaTeq® vaccine (Merck and Co Inc, West Point, PA) to the national immunization program in Iran.

Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study.

MMR II (M-M-R II [Merck & Co, Inc.]) is currently the only measles, mumps, and rubella (MMR) vaccine licensed in the United States. A second MMR vaccine would mitigate the potential risk of vaccine su...

Efficacy of China-made praziquantel for treatment of Schistosomiasis haematobium in Africa: A randomized controlled trial.

In the roadmap on the neglected tropical diseases (NTD) the World Health Organization (WHO) aims at attaining at least 75% coverage of preventive chemotherapy in pre-school and school-age children by ...

AMCP Partnership Forum: Integrated Delivery Networks' Role in Pharmaceutical Value-Based Agreements.

Health care payment models that reward value over volume have the potential to improve patient care and control rising costs. These payment models are increasingly being implemented by a range of care...

Mechanistic understanding of abnormal reverse phase chromatographic behavior of basic analytes in the presence of sodium dodecyl sulfate.

In the process of dissolution method development for Merck proprietary compound A, a basic analyte, abnormal chromatographic behavior involving peak splitting and retention time shifting in the presen...

Clinical Trials [93 Associated Clinical Trials listed on BioPortfolio]

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age

The purpose of this study is to evaluate the immunogenicity and safety of GSK Biologicals' trivalent MMR (Priorix®), comparing it to Merck's MMR vaccine (M-M-R®II), which is approved for...

Study of EMD531444 in Subjects With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy

Darmstadt, Germany, June 17 2010 - Merck Serono, a division of Merck KGaA, and its U.S. affiliate, EMD Serono, Inc. today announced that they are resuming their Stimuvax® (BLP25 liposome ...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Glucophage Extended Release (GXR) China Bioequivalence Study (Nantong - Darmstadt)

The study will assess the bioequivalence between single doses of GXR manufactured in Merck Nantong China (test drug) and GXR manufactured in Merck Darmstadt Germany (reference drug) under ...

Glucophage® Extended Release (XR) 750 Milligram (mg) Indonesia Bioequivalence (BE) Study

The purpose of this study is to assess bioequivalence between metformin hydrochloride (Glucophage® XR) manufactured in PT Merck Tbk, Indonesia (test drug) and metformin hydrochloride (Glu...

Companies [143 Associated Companies listed on BioPortfolio]

The Merck Foundation

The Merck Foundation is a U.S.-based, private charitable foundation. Established in 1957 by Merck, a global health care leader, the Foundation is funded entirely by the company an...

Merck Foundation

The Merck Foundation is a U.S.-based, private charitable foundation. Established in 1957 by Merck, a global health care leader, the Foundation is funded entirely by the company an...

Merck & Co

Here you will find an overview of our activities in the core businesses of pharmaceuticals and chemicals. We illustrate the structure of our company. We present the Executive Board of Merck KGaA. ...

Merck Animal Health

Today's Merck is a global healthcare leader working to help the world be well. Merck Animal Health, known as MSD Animal Health outside the United States and Canada, is the global ...

Merck Serono

Merck Serono is the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, a global pharmaceutical and chemical company. Headquartered in Geneva, Switzerland, Merck Serono ...

More Information about "Merck Merck" on BioPortfolio

We have published hundreds of Merck Merck news stories on BioPortfolio along with dozens of Merck Merck Clinical Trials and PubMed Articles about Merck Merck for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Merck Merck Companies in our database. You can also find out about relevant Merck Merck Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record